Lin YC - Search Results

1

Everolimus in metastatic renal cell carcinoma: preliminary experience from Chang Gung Memorial Hospital.

Huang WK, Liaw CC, Pang ST, Chuang CK, Chiang YJ, Wu CT, Chang YH, Wang HM, Lin YC, Hsieh JJ, Ou LY, Tsai SI, Yang CH, Yang CT, Chang JW. Huang WK, et al. Among authors: lin yc. Chang Gung Med J. 2012 Sep-Oct;35(5):402-7. doi: 10.4103/2319-4170.105478. Chang Gung Med J. 2012. PMID: 23127345 Free article.

2

Reduced maintenance of complete protection from emesis for women during chemotherapy cycles.

Liaw CC, Chang HK, Liau CT, Huang JS, Lin YC, Chen JS. Liaw CC, et al. Among authors: lin yc. Am J Clin Oncol. 2003 Feb;26(1):12-5. doi: 10.1097/00000421-200302000-00003. Am J Clin Oncol. 2003. PMID: 12576917 Clinical Trial.

3

Mitomycin C (MMC) with weekly 24-hour infusions of high-dose 5-fluorouracil and leucovorin in patients with advanced gastric cancer.

Chen JS, Lin YC, Liau CT, Wang CH, Liaw CC. Chen JS, et al. Among authors: lin yc. Chang Gung Med J. 2003 Jun;26(6):433-9. Chang Gung Med J. 2003. PMID: 12956290 Free article.

4

A modified low-dose regimen of mitoxantrone and prednisolone in patients with androgen-independent prostate cancer.

Sheen WC, Chen JS, Wang HM, Yang TS, Liaw CC, Lin YC. Sheen WC, et al. Among authors: lin yc. Jpn J Clin Oncol. 2004 Jun;34(6):337-41. doi: 10.1093/jjco/hyh064. Jpn J Clin Oncol. 2004. PMID: 15333686

5

Phase I dose escalation study of oxaliplatin combined with oral tegafur-uracil and leucovorin in patients with advanced gastric cancer.

Chen JS, Huang JS, Yang TS, Lin YC, Wang HM, Liau CT, Rau KM. Chen JS, et al. Among authors: lin yc. Anticancer Drugs. 2005 Jan;16(1):47-51. doi: 10.1097/00001813-200501000-00006. Anticancer Drugs. 2005. PMID: 15613903 Clinical Trial.

6

Liaw CC, Wang CH, Chang HK, Wang HM, Huang JS, Lin YC, Chen JS. Liaw CC, et al. Among authors: lin yc. J Pain Symptom Manage. 2005 Oct;30(4):359-66. doi: 10.1016/j.jpainsymman.2005.08.008. J Pain Symptom Manage. 2005. PMID: 16256900 Free article. Clinical Trial.

7

A phase II randomized study of two taxanes and cisplatin for metastatic breast cancer after anthracycline: a final analysis.

Lin YC, Chang HK, Chen JS, Wang HM, Yang TS, Liaw CC. Lin YC, et al. Jpn J Clin Oncol. 2007 Jan;37(1):23-9. doi: 10.1093/jjco/hyl124. Epub 2006 Dec 15. Jpn J Clin Oncol. 2007. PMID: 17172351 Clinical Trial.

8

Weekly paclitaxel in women with heavily pretreated metastatic breast cancer: a retrospective analysis of cases treated at the Chang Gung Memorial Hospital.

Lu CH, Lin YC, Chang HK. Lu CH, et al. Among authors: lin yc. Chang Gung Med J. 2007 Jan-Feb;30(1):33-40. Chang Gung Med J. 2007. PMID: 17477027 Free article.

9

An open-labeled phase II trial of docetaxel in combination with cisplatin as first-line cytotoxic therapy for anthracycline-naive patients with metastatic breast cancer.

Lin YC, Chang HK, Shen WC, Chen JS, Wang HM. Lin YC, et al. Anticancer Drugs. 2007 Nov;18(10):1213-9. doi: 10.1097/CAD.0b013e3282ee3af2. Anticancer Drugs. 2007. PMID: 17893523 Clinical Trial.

10

Oral bioavailability of a novel paclitaxel formulation (Genetaxyl) administered with cyclosporin A in cancer patients.

Chu Z, Chen JS, Liau CT, Wang HM, Lin YC, Yang MH, Chen PM, Gardner ER, Figg WD, Sparreboom A. Chu Z, et al. Among authors: lin yc. Anticancer Drugs. 2008 Mar;19(3):275-81. doi: 10.1097/cad.0b013e3282f3fd2e. Anticancer Drugs. 2008. PMID: 18510173 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,463 results

Search Page

Filters